Top Story

Risks, benefits of power morcellation differ based on patient age

October 8, 2015

Minimally invasive hysterectomies with electric power morcellation have varying risks and benefits depending on a woman’s age, according to results of a cohort stimulation modeling study.

Overall, the risks associated with the procedure appeared greater in older women, whereas the benefits appeared greater in younger women.

Susan Vadaparampil In the Journals

Young black women have higher frequency of BRCA mutations than previously thought

October 8, 2015
The prevalence of BRCA mutations among young black women living in Florida appears greater than previously reported for non-Hispanic white women, according to findings…
In the JournalsPerspective

Genetic testing may improve myeloma risk stratification, treatment

October 8, 2015
Researchers have identified significantly mutated genes in patients with newly diagnosed myeloma that may be used to improve risk stratification and treatment at disease…
Frank A. Sinicrope, MD In the Journals

Tumor mutations, survival in stage 3 colon cancer differ by race

October 8, 2015
Genetic tumor mutations status in BRAF and KRAS genes and survival rates in stage 3 colon cancer patients differ based on race, according to an analysis of a phase 3…
In the Journals

Lung cancer screening does not increase unnecessary surgeries

October 8, 2015
Adoption of a lung cancer screening program that used a standard reporting system did not lead to increased rates of surgical interventions for noncancerous disease…
More News Headlines »
Diabetic Eye Disease Consults: Volume 1, Number 1

Updates in Melanoma 2015: Entering a New Therapeutic Era

This activity is supported by an educational grant from Merck & Co., Inc.

The incidence of melanoma, an aggressive disease that accounts for approximately 75% of skin-cancer-related deaths, is…
More »
VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

September 30, 2015
The development of new treatments for patients with advanced melanoma in the past decade has been…
More »
Hematology Oncology Case Consults

The Patient with Pancreatic Cancer

No commercial support for this activity.

Pancreatic cancer only accounts for 3% of cancer cases, but it is the fourth leading cause of cancer-related death…
More »